Drag a card by its title · ⚙ to size, swap or remove

The company

Tenaya Therapeutics, Inc.

TNYA · Nasdaq

Health CareBiotechnologyNot moving yet

TNYA stood above a rising 150-day average in 7 of the last 52 weekly readings, and has been out of that trend for the last 45 weeks. It is 47.5% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 45
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $11.9M
Officials’ trades on record: 0
Institutions holding: 99 (+1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 7 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months23

Buyers · sellers0 · 6

Who	Did	Shares	Traded
Whittemore TingleyChief Medical Officer	sold	1,637at $0.7098	17 Aug 2026filed 17 Aug 2026
Whittemore TingleyChief Medical Officer	sold	1,637at $0.7098	17 Aug 2026filed 17 Aug 2026
Whittemore TingleyChief Medical Officer	sold	1,871at $0.7098	17 Aug 2026filed 17 Aug 2026
Whittemore TingleyChief Medical Officer	sold	2,279at $0.7098	17 Aug 2026filed 17 Aug 2026
Faraz AliChief Executive Officer	sold	5,837at $0.7097	17 Aug 2026filed 17 Aug 2026
Faraz AliChief Executive Officer	sold	3,969at $0.7098	17 Aug 2026filed 17 Aug 2026
Faraz AliChief Executive Officer	sold	5,020at $0.7097	17 Aug 2026filed 17 Aug 2026
Faraz AliChief Executive Officer	sold	7,406at $0.7097	17 Aug 2026filed 17 Aug 2026
Tomohiro HigaSVP, Finance	sold	1,485at $0.7932	18 May 2026filed 19 May 2026
Whittemore TingleyChief Medical Officer	sold	3,121at $0.7936	18 May 2026filed 19 May 2026
Faraz AliChief Executive Officer	sold	3,390at $0.7934	18 May 2026filed 19 May 2026
Column Group Iii Gp, Lp10% owner	sold	1,649,281at $0.5624	25 Feb 2026filed 26 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders99+1 on the quarter

New · exited20 · 20

Reported value$37.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026	7,101,263$5.2M	-1,381,025−16.3%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026	6,429,648$4.8M	+972,982+17.8%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026	4,566,774$3.4M	+366,774+8.7%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026	4,281,100$3.2M	+567,339+15.3%
BlackRock, Inc.added · filed 7 Aug 2026	4,008,719$3.0M	+304,764+8.2%
Empery Asset Management, LPreduced · filed 11 Aug 2026	3,863,115$2.9M	-423,818−9.9%
MARSHALL WACE, LLPadded · filed 13 Aug 2026	3,503,178$2.6M	+797,788+29.5%
Burkehill Global Management, LPunchanged · filed 14 Aug 2026	2,000,000$1.5M	00.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	1,834,674$1.4M	+274,735+17.6%
ADAR1 Capital Management, LLCadded · filed 14 Aug 2026	1,555,500$1.1M	+47,700+3.2%